Shian Yi Jessele Lai

Ms. Shian Yi Jessele Lai

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KLKai Lin Lee
Kai Lin Lee
SLShian Yi Jessele Lai
Shian Yi Jessele Lai
PHPeh Joo Ho
Peh Joo Ho
HWHung Chew Wong
Hung Chew Wong
KCKaren Kaye Casida
Karen Kaye Casida
SGSerene Si Ning Goh
Serene Si Ning Goh
Background: Idiopathic granulomatous mastitis (IGM) is a rare, benign, chronic inflammatory breast condition that poses diagnostic and therapeutic challenges. While corticosteroids are standard first-line therapy, some patients require additional immunomodulation, such as methotrexate. Predictive factors for step-up therapy remain poorly characterized. This study aimed to identify clinical, imaging, and pathological factors predictive of step-up therapy in IGM and evaluate associations between treatment approach and outcomes. Methods: A retrospective cohort study of women diagnosed with IGM was conducted between May 2022 and June 2024 at a tertiary center in Singapore. Data on demographics, clinical presentation, imaging, histopathology, and treatment were extracted. Step-up therapy was defined as methotrexate use following corticosteroids. Primary outcome was predictors of step-up therapy; secondary outcomes included treatment success, relapse, surgery, and time to remission. Statistical analyses included chi-square/Fisher’s exact tests, Cox models, and Kaplan-Meier analysis. Results: Fifty-two women (median age 39 years) were included; 26 (50%) required step-up therapy. Predictors included oral contraceptive (OCP) use (RR 1.92; 95% CI 1.45–2.53; p < 0.001), smoking (RR 2.00; 95% CI 1.49–2.69; p < 0.001), flares (RR 2.33; 95% CI 1.44–3.79; p = 0.002), and percutaneous aspiration (RR 2.10; 95% CI 1.53–2.88; p = 0.025). Patients receiving methotrexate had lower relapse rates (RR 1.23; 95% CI 1.12–1.36; p < 0.001) but longer time to remission (adjusted HR 0.09; 95% CI 0.02–0.46; p = 0.004). Conclusions: OCP use, smoking, flares, and aspiration need may predict step-up therapy in IGM. Early identification could guide a more personalized, potentially top-down treatment.

17 July 2026 in Postgraduate Medical Journal
Verified
Journal Article
Closed access
SLShian Yi Jessele Lai
Shian Yi Jessele Lai
DCDarren J H Choo
Darren J H Choo
RLRachelle S R Lai
Rachelle S R Lai
JLJoel Lim
Joel Lim
DTDesmond B Teo
Desmond B Teo
INIsaac K S Ng
Isaac K S Ng
Productive struggle may be conceptualized as an educational construct which incorporates mental stress and ‘struggle’ within ongoing instruction to develop perseverance and deepen understanding rather than focus on the solution. Medicine, which involves diagnostic uncertainty and varied clinical presentations, necessitates the development of adaptive reasoning and critical thinking—skills that can be honed by the productive struggle process. In this article, we sought to discuss the concept of productive struggle in medical education, by exploring why it is important to facilitate clinical learning and highlight practical strategies and potential pitfalls such as patient and psychological safety with this pedagogical model. We proposed three strategies to incorporate productive struggle in medical education—namely core tutoring, case-based discussions, and clinical simulations.

11 June 2026 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
SLShian Yi Jessele Lai
Shian Yi Jessele Lai
RLRachelle S. R. Lai
Rachelle S. R. Lai
DCDarren J. H. Choo
Darren J. H. Choo
INIsaac Ks Ng
Isaac Ks Ng

28 January 2026 in The Clinical Teacher
Verified
Journal Article
Closed access
HNHosea Nyanavoli
Hosea Nyanavoli
SLShian Yi Jessele Lai
Shian Yi Jessele Lai
INIsaac Ks Ng
Isaac Ks Ng

Verified
Journal Article
Open access
PDF file
TLTony Li
Tony Li
VPVinay B. Panday
Vinay B. Panday
SLShian Yi Jessele Lai
Shian Yi Jessele Lai
NGNicholas Gao
Nicholas Gao
BLBeth Lim
Beth Lim
KPKian-Keong Poh
Kian-Keong Poh
Introduction: Assessment of left ventricular (LV) systolic function is important in valvular heart disease. The global LV contractility index, dσ*/dtmax, is load-independent and has been reported to be associated with clinical outcomes in heart failure and aortic stenosis. We aim to assess if dσ*/dtmax could predict adverse outcomes in patients with severe mitral regurgitation (MR). Methodology: We studied dσ*/dtmax in a cohort of 127 patients with isolated severe primary MR and preserved LVEF ≥ 60%. Patients with prior valvular intervention or concurrent valvular disease were excluded. We tested dσ*/dtmax against a composite of adverse outcomes including all-cause mortality, heart failure hospitalization, and mitral valve intervention. Results: The cohort had a mean age of 58 years old and was predominantly male. Of the 127 patients, eight (6.3%) needed subsequent hospitalization for heart failure, while 30 (23.6%) and 11 (8.7%) patients underwent mitral valve repair and replacement, respectively, And 14 (11.0%) passed away. Of the patients (n = 54 (42.5%)) who had an adverse outcome during follow-up, dσ*/dtmax demonstrated an independent association with composite adverse outcome, including its individual components. On ROC analysis, a cut-off of 2.15 s−1 was identified. Based on this cut-off, dσ*/dtmax retained an independent association with composite adverse outcome after adjusting for covariates including age, sex, ischemic heart disease, pulmonary artery systolic pressure, and left ventricular end systolic diameter. Conclusions: In patients with severe primary MR and preserved LVEF, reduced dσ*/dtmax was an independent predictor of adverse outcomes. It can be a useful addition to the armamentarium for assessing patients with severe MR.

Verified
Journal Article
Open access
PDF file
HWHon Jen Wong
Hon Jen Wong
TKTze Siang Koh
Tze Siang Koh
ZBZong Rui Bai
Zong Rui Bai
SLShian Yi Jessele Lai
Shian Yi Jessele Lai
NGNicholas L. X. Gao
Nicholas L. X. Gao
Ching-Hui SiaChing-Hui Sia
Ching-Hui Sia
Objectives: Severe mitral regurgitation (MR) has been associated with significant morbidity and mortality, necessitating effective risk stratification. The H2FPEF score has demonstrated prognostic value in other cardiac disorders. This study evaluates the prognostic utility of a modified version of the H2FPEF score for severe MR with preserved ejection fraction. Methods and Results: Patients from a tertiary cardiovascular referral center with consecutive index echocardiographic diagnoses of severe MR were included. We excluded patients with secondary MR, reduced LVEF ( 25 kg/m2) as opposed to the original cutoff (BMI > 30 kg/m2). Patients were stratified based on the modified score into low (0–1), intermediate (2–5), and high (6–9) groups. The primary endpoint, a composite of all-cause mortality and first heart failure hospitalization (HFH), was analyzed using multivariate Cox regression. A total of 388 patients (low 57 [14.7%]; intermediate 218 [56.2%]; high 113 [29.1%] modified H2FPEF score) were included with a median follow-up duration of 4.53 years (interquartile range 2.61 to 6.60). Patients with a high modified H2FPEF score were older, more likely to have hyperlipidemia, diabetes, end-stage renal disease, higher NYHA class, and lower LVEF. Malay ethnicity, hyperlipidemia, diabetes, end-stage renal disease and a higher indexed left atrial diameter were independently associated with greater modified H2FPEF score. High and intermediate modified H2FPEF scores were associated with the primary endpoint (HR 9.17, 95% CI 2.15–39.1 and 6.71, 95% CI 1.62–27.9 respectively) versus low scores. However, a Fine–Gray regression showed no difference in subdistribution hazards of first HFH between high and intermediate scores. Conclusions: The modified H2FPEF score may facilitate risk stratification for all-cause mortality and first HFH in patients with severe primary MR and preserved ejection fraction.